1. Home
  2. Analysis
  3. Oxycodone
  4. Libtayo

Oxycodone and Libtayo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone (oxycodone hydrochloride) and Libtayo (cemiplimab-rwlc). Common drug interactions include disease progression among females and ischaemic stroke among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone and Libtayo. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Libtayo?

Libtayo has active ingredients of cemiplimab-rwlc. eHealthMe is studying from 1,161 Libtayo users. Check the latest studies of Libtayo.

On Jul, 11, 2026

21 people who take Oxycodone and Libtayo together, and have interactions are studied.

Oxycodone and Libtayo drug interactions.

What are the common drug interactions of Oxycodone and Libtayo, by gender? *:

female:

  1. Disease progression

male:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Pyrexia (fever)
  3. Interstitial lung disease
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Malignant neoplasm progression (cancer tumour came back)
  6. Ulcerative keratitis (ulcerative inflammation of the cornea)
  7. Uveitis (inflammation of the uvea)
  8. Cough
  9. Diarrhoea
  10. Disease progression

What are the common drug interactions of Oxycodone and Libtayo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Disease progression

60+:

  1. Pyrexia (fever)
  2. Cough
  3. Diarrhoea
  4. Nausea (feeling of having an urge to vomit)
  5. Viral infection
  6. Vomiting
  7. Interstitial lung disease

What are the existing conditions these people have? *

  1. Cancer Pain: 12 people, 57.14%
  2. Nicotine Dependence: 11 people, 52.38%
  3. Lung Cancer - Non-Small Cell (lung cancer): 11 people, 52.38%
  4. Constipation: 11 people, 52.38%
  5. Metastatic Squamous Cell Carcinoma (cancer of squamous cells spreads to other part): 5 people, 23.81%
  6. Nausea And Vomiting: 4 people, 19.05%
  7. Nausea (feeling of having an urge to vomit): 4 people, 19.05%
  8. High Blood Pressure: 4 people, 19.05%
  9. Infection: 3 people, 14.29%
  10. High Blood Cholesterol: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and Libtayo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxycodone and Libtayo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Libtayo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Libtayo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and cemiplimab-rwlc (the active ingredients of Oxycodone and Libtayo, respectively), and Oxycodone and Libtayo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.